Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines

Clinical Cancer Research

Volumn 7, Issue 2, 2001, Pages 391-399

  Hahm, Hillary A ^a,c   Dunn, Valerie R ^a   Butash, Kimberly A ^a,d   Deveraux, Wendy L ^a   Woster, Patrick M ^b   Casero, Patrick M ^a   Davidson, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Northwest Georgia Oncology Centers   (United States)

^d Life Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CISPLATIN; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; FLOXURIDINE; FLUOROURACIL; N1 ETHYL N11 [(CYCLOHEPTYL)METHYL] 4,8 DIAZAUNDECANE; N1 ETHYL N11 [(CYCLOPROPYL)METHYL] 4,8 DIAZAUNDECANE; NAVELBINE; PACLITAXEL; POLYAMINE DERIVATIVE; PUTRESCINE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; DOXORUBICIN; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; PACLITAXEL; POLYAMINES; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0035120259     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues
2. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy
3. Endogenous and exogenous polyamines in support of tumor growth
4. Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy
5. Synthetic polyamine analogues as antineoplastics
6. Antiproliferative properties of polyamine analogues: A structure-activity study
7. 1-acetyltransferase activity, polyamine pool depletion and growth inhibition in human melanoma cell lines
8. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth
9. 12-bis(ethyl)spermine
10. Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines
11. 11-Diethylnorspermine on a human bladder tumor xenograft in nude athymic mice
12. 11-diethylnorspermine administered by multiple injection or continuous infusion
13. Polyamine analogue induction of programmed cell death in human lung tumor cells
14. Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue
15. 11-diethylnorspermine in patients with advanced malignancy
16. 11diethylnorspermine (DENSPM) in patients with non-small cell lung cancer (NSCLC)
17. Polyamine-DNA nexus: Structural ramifications and biological implications
18. Polyamine depletion is associated with altered chromatin structure in HeLa cells
19. Effects of α-difluoromethylornithine and 5-fluorouracil on the proliferation of a human colon adenocarcinoma cell line
20. Inhibition of growth of human or hamster pancreatic cancer cell lines by α-difluoromethylornithine alone and combined with cis-diaminedichloroplatinum(II)
21. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion
22. Combined effects of α-difluoromethylornithine and doxorubicin against pancreatic cancer cell lines in culture
23. Reduced cytocidal efficacy for Adriamycin in cultured human carcinoma cell depleted of polyamines by difluoromethylornithine treatment
24. 8bis(ethyl)spermidine (BESpd) or difluoromethylornithine (DFMO) on the topoisomerase II mediated formation of 4′-(9-acridinylamino)methanesulfon-M anisidide (m-AMSA) induced cleavable complex in the human lung carcinoma line NCI H157
25. Effect of polyamine depletion by α-difluoromethylornithine or (2R.5R)-6-heptyne 2.5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells
26. Schedule-dependent interaction of α-difluoromethylornithine and cis-diaminedichloroplatinum(II) against human and hamster pancreatic cancer cell lines
27. Contradictory antitumor efficacies produced by the combination of DNA attacking drugs and polyamine antimetabolites
28. Combination therapy using polyamine synthesis inhibitor α-difluoromethylornithine and Adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma
29. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in Ppolyamine-depleted and control human adenocarcinoma cells
30. Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy
31. Effect of α-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diaminedichloroplatinum(II) cytotoxicity, DNA interstrand crosslinking, and growth in human brain tumor cell lines in vitro
32. Schedule dependent potentiation of antitumor drug effects by α-difluoromethylornithine in human gastric carcinoma cell in vitro
33. In vitro response of a human colon tumor xenograft and a lung adenocarcinoma cell line to α-difluoromethylornithine alone and in combination with 5-fluorouracil and doxorubicin
34. Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase II inhibitors
35. Difluoromethylornithine antagonizes Taxol cytotoxicity in MCF-7 human breast cancer cells
36. Additive growth-inhibitory effects of DL-α-difluoromethylornithine and antiestrogens on MCF-7 breast cancer cell line
37. 1-acetyltransferase (SSAT) and as potential anti-tumor agents
38. Hepsulfam sensitivity in human breast cancer cell lines: The role of glutathione and glutathione-S-transferase in resistance
39. An improved MTT assay
40. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
41. The importance of dose intensity in chemotherapy of metastatic breast cancer
42. Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reverse phase liquid chromatography: Improved separation systems for polyamines in cerebrospinal fluid, urine and tissues
43. Role of the methylene backbone in the antiproliferative activity of polyamine analogs of L1210 cells
44. 12-bis(ethyl)spermine effect on growth of cis-diaminedichloroplatinum(II)-sensitive and-resistant human ovarian-carcinoma cell lines
45. 1-acetyltransferase in a human large cell lung carcinoma
46. 11-bis(ethyl)norspermine
47. The role of polyamine catabolism in polyamine analogue-induced programmed cell death
48. 1-(N-Alkylamino)-11(N-ethylamine)-4,8-diazaundecanes: Simple synthetic polyamine analogues that differentially alter tubulin polymerization
49. 5-Fluorouracil (Fura)
50. Vinorelbine (Navelbine). A third-generation Vinca alkaloid
51. Polyamine starvation causes disappearance of actin filaments and microtubules in polyamine-auxotrophic CHO cells
52. The effect of polyamines on tubulin assembly
53. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
54. p53 status and the efficacy of cancer therapy in vivo
55. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells
56. Unsymmetrically substituted polyamine analogue induces caspase-independent programmed cell death in Bcl-2-overexpressing cells